Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 2Tumor-Agnostic 1Other hematologic neoplasm 1

Conditions

Sarcopenia 2Liver Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hand Strength × Gastrointestinal × Clear all
NCT05443230 2023-09-13

Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment

First Affiliated Hospital of Wenzhou Medical University

Unknown
200 enrolled
Gastrointestinal

Liver Neoplasms, Sarcopenia

NCT05448222 2023-09-13

Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic Therapies

First Affiliated Hospital of Wenzhou Medical University

Unknown
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡